ACULAR LS®

Drug Information Related Patent
Hold Company
ABBVIE
Dosage and Administration
SOLUTION/DROPS;OPHTHALMIC
Specification
0.4%
Indication
ACULAR LS® is used to reduce eye pain after corneal refractive surgery and calcination/sting.
API
KETOROLAC TROMETHAMINE
API Structure
Drug Patent
Patent NoExpiration Date
80083382027/5/24
8008338*PED2027/11/24
82072152024/5/28
8207215*PED2024/11/28
83779822024/5/28
8377982*PED2024/11/28
85414632024/5/28
8541463*PED2024/11/28
86481072024/5/28
89069502024/5/28
89462812024/5/28
92161672024/5/28
API Patent
Patent NoExpiration Date
80083382027/5/24
8008338*PED2027/11/24
82072152024/5/28
8207215*PED2024/11/28
83779822024/5/28
8377982*PED2024/11/28
85414632024/5/28
8541463*PED2024/11/28
86481072024/5/28
89069502024/5/28
89462812024/5/28
92161672024/5/28

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top